Table 1 Demographic and clinical characteristics of the study population.
From: Influence of kidney replacement therapy on indirect calorimetry in critically ill patients
Variable | Total cohort (N = 100) | CVVHD (N = 77) | SLEDD (N23) | p(CVVHD vs. SLEDD) |
|---|---|---|---|---|
Age (years) | 64.0 [55.3–74.0] | 64.0 [55.0–74.0] | 65.0 [56.0–76.0] | 0.67 |
Males (%) | 75.0 | 71.4 | 87.0 | 0.17 |
Actual body weight (kg) | 92.0 ± 24.5 | 91.9 ± 23.3 | 92.3 ± 28.6 | 0.94 |
Ideal or adjusted body weight (kg) | 77.7 ± 14.2 | 76.9 ± 13.7 | 80.3 ± 15.8 | 0.32 |
APACHE-II score | 30.9 ± 8.9 | 30.5 ± 8.5 | 32.1 ± 10.0 | 0.44 |
SOFA score on IC day | 11.3 ± 3.8 | 11.8 ± 3.9 | 9.5 ± 2.4 | 0.004 |
Vasopressor infusion during IC (%) | 61.0 | 68.8 | 34.8 | 0.006 |
MAP during IC (mm Hg) | 75.0 [68.0–82.0] | 76.0 [66.5–83.5] | 72.0 [64.0–82.0] | 0.39 |
Continuous sedation during IC (%) | 75.0 | 84.4 | 43.5 | <0.001 |
Body temperature during IC (°C) | 37.1 ± 0.8 | 37.0 ± 0.8 | 37.2 ± 0.7 | 0.16 |
Room temperature (°C) | 23.0 ± 1.1 | 23.0 ± 1.0 | 23.2 ± 1.1 | 0.49 |
Humidity (%) | 37.5 ± 10.4 | 37.8 ± 10.1 | 36.5 ± 11.7 | 0.62 |
